Ondansetron vs Rituximab
Ondansetron vs Rituximab: Overview
This comparison examines the pharmacological differences between Ondansetron and Rituximab.
Mechanism of Action
Ondansetron: Selective 5-HT3 receptor antagonist.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Ondansetron — 3-5 hours; Rituximab — 22 days.
Chemical Properties
Molecular Formula: Ondansetron — C18H19N3O.
Molecular Weight: Ondansetron — 293.3660 g/mol.
Type: Ondansetron — Small molecule; Rituximab — Antibody.